PRODUCTS & SERVICES
CUSTOM OLIGO SYNTHESISRNA SEQUENCINGFLUORESCENT IN SITU HYBRIDIZATIONPERSONALIZED DIAGNOSTICS
To be considered for this opportunity, you must have a bachelor’s degree in chemistry (preferably organic chemistry, biochemistry) with at least 1 year of experience in a commercial lab or a master’s degree in chemistry (preferably organic chemistry, biochemistry) with no extra experience. Training will be provided on the job. Motivation to work in a laboratory environment and interest in solid-phase synthesis are highly welcome.
You have strong technical and analytical skills.
You are detail-oriented and can work under minimal supervision.
You can prioritize multiple tasks.
You pay high attention to safety and procedures.
You possess a strong working knowledge of Microsoft Office.
You can communicate freely in English.
Synthesis, cleavage, deprotection, and QC sampling of oligonucleotides produced for internal R&D purposes as well as for commercial orders. Packaging & shipment of produced goods. Basic maintenance & troubleshooting of laboratory equipment.
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.